UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029137
Receipt number R000033059
Scientific Title The evaluation of treatment effect of combined different drugs on herpes zoster neuralgia (PHN) via epidural block
Date of disclosure of the study information 2019/08/01
Last modified on 2017/09/13 21:44:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The evaluation of treatment effect of combined different drugs on herpes zoster neuralgia (PHN) via epidural block

Acronym

The effect of combined different drugs on herpes zoster neuralgia (PHN) via epidural block

Scientific Title

The evaluation of treatment effect of combined different drugs on herpes zoster neuralgia (PHN) via epidural block

Scientific Title:Acronym

The effect of combined different drugs on herpes zoster neuralgia (PHN) via epidural block

Region

Asia(except Japan)


Condition

Condition

Herpes zoster neuralgia

Classification by specialty

Medicine in general Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effect of combined different drugs on herpes zoster neuralgia (PHN) via epidural block

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

the offect of pain variation effect different drugs on herpes zoster neuralgia (PHN)

Key secondary outcomes

none


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Methylprednisolone80mg + 0.1%ropivacaine + sufentanil100ug+0.9%NaCl=400ml, continuous epidural injection for 8day

Interventions/Control_2

Methylprednisolone80mg + 0.1%ropivacaine + sufentanil100ug+ketamine100mg+0.9%NaCl=400ml, continuous epidural injection for 8day

Interventions/Control_3

Methylprednisolone80mg + 0.1%ropivacaine ++ketamine200mgg+0.9%NaCl=400ml, continuous epidural injection for 8day

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1 older than 50 years inpatient, younger than 90 years inpatient
2 dermatome below C6
3 Moderate to serve pain(NRS baseline mort than 6 )persisting for more than 3 months after onset of herpes zoster rash
4 Uncontrollable pain by conventional drugs
5 Normal cognitive and communicative ability and ability to complete self-report questionnaires

Key exclusion criteria

1 patients with facial involvement
2 known sensitivity to methylprednisolone, ketamine,ropivacaine, and sufentanil
3 serious mental or psychiatric illness
4 Drug addiction and alcoholism
5 Bacterial infection of the skin overlying the vertebra of the affected dermatome
6 bronchial asthma, serve hypertension, serious cardiovascular disease, serve hepatic and renal dysfunction, serious hematological disease
7 patients participated in other clinical study in recent 6 months
8 Non-compliant patient who will not complete relative treatment and questionnaires.
9 Patients with any unsuitable situation decided by researchers will be excluded.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Guolin Wang

Organization

Department of Anesthesiology, General Hospital of Tianjin Medical University

Division name

General Hospital of Tianjin Medical University

Zip code


Address

No.154 Anshan Street, Heping District, 300054 Tianjin, PR China

TEL

+86-13662179014

Email

wang_guolin@hotmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Hongguang Chen

Organization

Department of Anesthesiology, General Hospital of Tianjin Medical University

Division name

General Hospital of Tianjin Medical University

Zip code


Address

No.154 Anshan Street, Heping District, 300054 Tianjin, PR China

TEL

+86-13662179014

Homepage URL


Email

daguang521521@163.com


Sponsor or person

Institute

Department of Anesthesiology, General Hospital of Tianjin Medical University

Institute

Department

Personal name



Funding Source

Organization

Department of Anesthesiology, General Hospital of Tianjin Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Tianjin Institute of Anesthesiology


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 13 Day

Last modified on

2017 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033059


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name